Last reviewed · How we verify
NCT02967315
Effects of Changes in Fluid Status on Right Ventricular Volumes and Function
NA trial testing Cardiac Magnetic Resonance Imaging (CMRI) in Tetralogy of Fallot in 4 participants. Completed in 18 March 2021.
18 March 2021
Quick facts
| Lead sponsor | University of Wisconsin, Madison |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 4 |
| Start date | 6 June 2014 |
| Primary completion | 18 March 2021 |
| Estimated completion | 18 March 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cardiac Magnetic Resonance Imaging (CMRI)
- Central venous line placement
- Chest X-ray
- Fluid administration — full drug profile →
- Blood Draw — full drug profile →
- Pregnancy test — full drug profile →
- Electrocardiogram
Conditions studied
- Tetralogy of Fallot — all drugs for Tetralogy of Fallot →
Sponsor
University of Wisconsin, Madison
Who can join
18 and older, any sex, with Tetralogy of Fallot. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the correlation between fluid volume status and right ventricular volume and function, in those with free pulmonary valve insufficiency after Tetralogy of Fallot (TOF) repair.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02967315
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tetralogy of Fallot
Currently open trials in the same condition.
- NCT06282926 — Role of 3D Echocardiography Knowledge-based Reconstruction in ACHD · active not recruiting
- NCT05809310 — Effects Branch PA Stenting d-TGA, ToF and TA · NA · recruiting
- NCT04713657 — Beta-blocker Administration for Cardiomyocyte Division · Phase 1 · recruiting
- NCT04106479 — NIRS in Congenital Heart Defects - Correlation With Echocardiography · recruiting
- NCT04084132 — Early Versus Later Re-valving in Tetralogy of Fallot With Free Pulmonary Regurgitation · NA · recruiting
Other University of Wisconsin, Madison trials
Trials by the same sponsor.
- NCT07440004 — Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts · Phase 1 · recruiting
- NCT07278466 — The COMParing App Support Strategies Study · NA · recruiting
- NCT07475104 — Redesigning Surgical Care for Patients in Wisconsin · NA · enrolling by invitation
- NCT07470723 — The ORIGIN-FH Study · NA · recruiting
- NCT06975657 — Well-being Skills for Reentry · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02967315 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Wisconsin, Madison
- Last refreshed: 14 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02967315.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing